AstraZeneca Reiterates Importance Of Salick To Developing Oncology
Executive Summary
AstraZeneca continues to see long-term value in Salick Health Care from the contact that the treatment clinics provide with current trends in oncology, AstraZeneca CEO Tom McKillop, PhD, said at a 1999 earnings review Feb. 24 in London.